LeadingTac

Shanghai, China · Founded 2019 · Privately Held (backing)

Developer of small-molecule innovative therapeutics intended for the treatment of autoimmune and tumor diseases. LeadingTac is based in Shanghai, China and was founded in 2019. Its last reported valuation was $8.5 million in Nov 2019. It has raised $63.8 million.

Last reported valuation
$8.5M
Oct 2026
Priced at
—
Total raised
$63.8M
Last round
—

Who backs LeadingTac?

8 investors
InvestorType
CDH InvestmentsPE / buyout
YuanBio Venture CapitalVenture capital
Lapam CapitalVenture capital
Hankang CapitalVenture capital
Zhangjiang GroupOther
Kangcheng Capital—
Tianrui Fengnian—
Yongkan Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

LeadingTac investors

8 investors are on record for LeadingTac, including CDH Investments, YuanBio Venture Capital, Lapam Capital and Hankang Capital.

Free account
More of LeadingTac with a free account
  • ·Watch LeadingTac: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like LeadingTac. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View